Two-stage least squares with treatment-covariate interactions for treatment effect heterogeneity
Anqi Zhao, Peng Ding, Fan Li

TL;DR
This paper examines the conditions under which interacted two-stage least squares (2sls) accurately estimates treatment effect heterogeneity with covariates in instrumental variable analyses, highlighting limitations and providing theoretical insights.
Contribution
It clarifies the causal interpretation of interacted 2sls under the LATE framework and identifies key conditions for its consistency in estimating treatment heterogeneity.
Findings
Coefficients on treatment-covariate interactions are consistent under the linear IV-covariate interactions condition.
This condition holds only if the IV propensity score has at most K distinct values, limiting practical applicability.
Demeaned covariates in interacted 2sls can provide consistent estimates of the LATE under certain conditions.
Abstract
Treatment effect heterogeneity with respect to covariates is common in instrumental variable (IV) analyses. An intuitive approach, which we call the interacted two-stage least squares (2sls), is to postulate a working linear model of the outcome on the treatment, covariates, and treatment-covariate interactions, and instrument it using the IV, covariates, and IV-covariate interactions. We clarify the causal interpretation of the interacted 2sls under the local average treatment effect (LATE) framework when the IV is valid conditional on the covariates. Our main findings are threefold. First, we show that the coefficients on the treatment-covariate interactions from the interacted 2sls are consistent for estimating treatment effect heterogeneity with respect to covariates among compliers for any outcome-generating process if and only if the product of the IV propensity score and…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods in Clinical Trials · Innovative Microfluidic and Catalytic Techniques Innovation
